Telix Pharmaceuticals (Australia) Insiders

Telix Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of 0.0797 % which means that it generated a profit of $0.0797 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2049 %, meaning that it generated $0.2049 on every $100 dollars invested by stockholders. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Telix Pharmaceuticals' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 418.2 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 48.8 M in 2024. Common Stock Shares Outstanding is likely to drop to about 221.8 M in 2024. Net Loss is likely to gain to about (89 M) in 2024

Telix Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Telix Pharmaceuticals Benchmark Summation

Telix Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Telix Pharmaceuticals often depends on how effective the management is. Telix Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Telix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Telix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Telix Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Telix Pharmaceuticals. Check Telix Pharmaceuticals' Beneish M Score to see the likelihood of Telix Pharmaceuticals' management manipulating its earnings.

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.